Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system (Q41827081)

From Wikidata
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
scientific article published on September 1999
Language Label Description Also known as
English
Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system
scientific article published on September 1999

    Statements

    Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system (English)

    Identifiers